Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Biliary Tract Neoplasms × neratinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 34 Neoplasm Metastasis 10 Neoplasms 7 Brain Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Advanced Malignant Solid Tumors 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thrombocytosis 1 Solid Tumor 1 Salivary Gland Neoplasms 1 Recurrence 1 Rare Tumour 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1

Interventions

Gemcitabine 79 Cisplatin 63 Capecitabine 33 Oxaliplatin 30 durvalumab 29 pembrolizumab 22 Fluorouracil 22 Leucovorin 21 S 1 (combination) 15 lenvatinib 11 Nivolumab 11 Irinotecan 11 tremelimumab 10 Bevacizumab 9 Injections 7 130-nm albumin-bound paclitaxel 7 apatinib 6 Trastuzumab 6 Docetaxel 6 titanium silicide 5 surufatinib 5 camrelizumab 5 Immune Checkpoint Inhibitors 5 Drug Therapy 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 zanidatamab 4 irinotecan sucrosofate 4 gemcitabine-oxaliplatin regimen 4 envafolimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05615818 2025-04-23

SAFIR-ABC10

UNICANCER

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡